Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
LABD ETF — Direxion Daily S&P Biotech Bear 3X Shares
Direxion Daily S&P Biotech Bear 3X Shares (LABD)
Updated October 16, 2026.
Verdict as of October 16, 2026
It pays quarterly and its distribution rate is 3.17%. The latest total cash payment per current share, $0.071 with an ex-date of September 22, 2026, was 5.3% lower than the previous $0.075. These payments are unclassified; this does not establish a base-dividend change.
Sources: Direxion, Section 19a-1 notices, scoring methodology.
LABD is an ETF that tracks the S&P Biotech. its distribution rate is 3.17%, its trailing-12-month yield is 5.13%, its expense ratio is 1.07%. Total return is -100.0% over the past 11.4 years, 434.1 points behind SPY at 334.1%.
LABD dividend yield and income
Price as of 2026-10-16.
The distribution rate (3.17%) uses calculation basis unavailable. Trailing-12-month yield (5.13%) is the last year of cash distributions by ex-date divided by the current price. The dividend amount is $0.071. The ex-dividend date is 09/22/2026. The payment date is 09/29/2026.
| Ex-date | As paid | Per current share | Change from previous payment |
|---|---|---|---|
| 2026-09-22 | $0.071 | $0.071 | -5.3% Unclassified cash |
| 2026-06-23 | $0.075 | $0.075 | -11.8% Unclassified cash |
| 2026-03-24 | $0.085 | $0.085 | -62.9% Unclassified cash |
| 2025-12-23 | $0.229 | $0.229 | -11.9% Unclassified cash |
| 2025-09-23 | $0.026 | $0.26 | -29.7% Unclassified cash |
| 2025-06-24 | $0.037 | $0.37 | -32.7% Unclassified cash |
| 2025-03-25 | $0.055 | $0.55 | -56.3% Unclassified cash |
| 2024-12-23 | $0.126 | $1.26 | 117.2% Unclassified cash |
| 2024-09-24 | $0.058 | $0.58 | -34.8% Unclassified cash |
| 2024-06-25 | $0.089 | $0.89 | 34.8% Unclassified cash |
| 2024-03-19 | $0.066 | $0.66 | -22.4% Unclassified cash |
| 2023-12-21 | $0.085 | $0.85 | -55.7% Unclassified cash |
| 2023-09-19 | $0.192 | $1.92 | 92.0% Unclassified cash |
| 2023-06-21 | $0.1 | $1 | -54.1% Unclassified cash |
| 2023-03-21 | $0.218 | $2.18 | 137.0% Unclassified cash |
| 2022-12-20 | $0.092 | $0.92 | -90.8% Unclassified cash |
| 2020-03-24 | $0.05 | $10 | 257.1% Unclassified cash |
| 2019-12-23 | $0.014 | $2.8 | -76.3% Unclassified cash |
| 2019-09-24 | $0.059 | $11.8 | -32.2% Unclassified cash |
| 2019-06-25 | $0.087 | $17.4 | 55.4% Unclassified cash |
| 2019-03-19 | $0.056 | $11.2 | -70.7% Unclassified cash |
| 2018-12-27 | $0.191 | $38.2 | 122.1% Unclassified cash |
| 2018-09-25 | $0.086 | $17.2 | 258.3% Unclassified cash |
| 2018-06-19 | $0.024 | $4.8 | -40.0% Unclassified cash |
| 2018-03-20 | $0.004 | $8 | — |
| 2018 total | — | $68.2 | — |
| 2019 total | — | $43.2 | -36.7% |
| 2020 total | — | $10 | -76.9% |
| 2022 total | — | $0.92 | -90.8% |
| 2023 total | — | $5.95 | 546.7% |
| 2024 total | — | $3.39 | -43.0% |
| 2025 total | — | $1.409 | -58.4% |
| 2026 YTD total | — | $0.231 | -80.4% vs prior-year YTD |
LABD dividend growth
Trailing-12-month distributions versus the preceding 12 months changed -81.1%. The 1Y row below uses this same adjacent TTM cash-window comparison. The deepest trailing-12-month payout decline in the past five years is -92.80%.
| Window | Change |
|---|---|
| 1Y | -81.1% |
| 3Y | -92.4% |
LABD holdings and sector exposure
Holdings are not available for this snapshot.
LABD performance versus SPY
Price and return data through 2026-10-16.
Total return is -100.0% over the past 11.4 years, 434.1 points behind SPY at 334.1%. Over the past year its total return — price change plus distributions reinvested — is -71.2%. Its deepest 1-year drawdown was 81.5%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | 17.4% | — |
| 3M | 5.4% | — |
| 6M | -32.8% | — |
| YTD | -56.5% | — |
| 1Y | -71.2% | — |
| 2Y CAGR | — | -58.60% |
| 3Y CAGR | — | -64.80% |
| 5Y CAGR | — | -45.50% |
| 10Y CAGR | — | -56.80% |
| Since inception (11.4 years) | -100.0% | -54.40% |
LABD key facts
- Issuer
- Direxion
- Asset type
- ETF
- Asset class
- Equity
- Inception date
- 05/28/2015
- Expense ratio
- 1.07%
- Distribution rate
- 3.17%
- Distribution frequency
- Quarterly
- Trailing yield
- 5.13%
- Last close
- $8.96 (as of 2026-10-16)
- AUM
- $140,570,315
- Average volume
- 30242821.0
- Dividend
- $0.071
- Ex-dividend date
- 09/22/2026
- Payment date
- 09/29/2026
- Beta
- -3.08
How Dividend Vision calculates yield and returns
Distribution rate (3.17%) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (5.13%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: Direxion; Index: S&P Biotech; prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
LABD risks and drawbacks
LABD's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are quarterly, so cash flow is lumpy versus a monthly fund. Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 81.5%.
Who may consider LABD — and who may not
LABD may suit someone looking for moderate current income with a quality tilt. It is a weaker fit for investors who need monthly cash flow (LABD pays quarterly); investors hunting double-digit covered-call yields; investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on LABD
Frequently asked questions
Does LABD pay monthly?
No. LABD currently pays quarterly, not monthly.
What index does LABD track?
LABD tracks the S&P Biotech.
What is LABD's expense ratio?
LABD's expense ratio is 1.07%.
What is LABD's dividend yield?
LABD's distribution rate is 3.17%, paid quarterly, with a 1.07% expense ratio — calculation basis unavailable.
How has LABD's dividend grown?
Trailing-12-month distributions versus the preceding 12 months changed -81.1%. That is the same adjacent TTM cash-window comparison used in the dividend-history table.
When does LABD pay a dividend?
LABD pays quarterly. The dividend amount is $0.071. The ex-dividend date is 09/22/2026. The payment date is 09/29/2026.
How has LABD performed?
Total return is -100.0% over the past 11.4 years, 434.1 points behind SPY at 334.1%. Over the past year its total return — price change plus distributions reinvested — is -71.2%. Its deepest 1-year drawdown was 81.5%.
Is LABD a good investment?
Its distribution rate is 3.17% (calculation basis unavailable). Compare peers below rather than treating any single figure as a buy or sell.
More securities from Direxion.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.